These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

456 related items for PubMed ID: 17353779

  • 1. Combination of extended donor criteria and changes in the Model for End-Stage Liver Disease score predict patient survival and primary dysfunction in liver transplantation: a retrospective analysis.
    Silberhumer GR, Pokorny H, Hetz H, Herkner H, Rasoul-Rockenschaub S, Soliman T, Wekerle T, Berlakovich GA, Steininger R, Muehlbacher F.
    Transplantation; 2007 Mar 15; 83(5):588-92. PubMed ID: 17353779
    [Abstract] [Full Text] [Related]

  • 2. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
    Hayashi PH, Forman L, Steinberg T, Bak T, Wachs M, Kugelmas M, Everson GT, Kam I, Trotter JF.
    Liver Transpl; 2003 Jul 15; 9(7):737-40. PubMed ID: 12827562
    [Abstract] [Full Text] [Related]

  • 3. Association between donor-recipient serum sodium differences and orthotopic liver transplant graft function.
    Cywinski JB, Mascha E, Miller C, Eghtesad B, Nakagawa S, Vincent JP, Pesa N, Na J, Fung JJ, Parker BM.
    Liver Transpl; 2008 Jan 15; 14(1):59-65. PubMed ID: 18161840
    [Abstract] [Full Text] [Related]

  • 4. Prediction of graft dysfunction based on extended criteria donors in the model for end-stage liver disease score era.
    Briceño J, Ciria R, de la Mata M, Rufián S, López-Cillero P.
    Transplantation; 2010 Sep 15; 90(5):530-9. PubMed ID: 20581766
    [Abstract] [Full Text] [Related]

  • 5. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
    Yi NJ, Suh KS, Lee HW, Shin WY, Kim J, Kim W, Kim YJ, Yoon JH, Lee HS, Lee KU.
    Liver Transpl; 2009 May 15; 15(5):496-503. PubMed ID: 19399732
    [Abstract] [Full Text] [Related]

  • 6. Model for End-Stage Liver Disease (MELD) score and organ allocation from cadaveric donors for 198 liver transplantation procedures performed in a single center.
    Santori G, Andorno E, Morelli N, Casaccia M, Bottino G, Ghirelli R, Valente U.
    Transplant Proc; 2008 May 15; 40(6):1903-5. PubMed ID: 18675084
    [Abstract] [Full Text] [Related]

  • 7. Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list.
    Ferraz-Neto BH, Hidalgo R, Thomé T, Melo VA, Lobue A, Zurstrassen MP, Moraes JM, Meira-Filho SP, Rezende MB, Fonseca LE, Pandullo FL, Soeiro FS, Afonso RC.
    Transplant Proc; 2007 Oct 15; 39(8):2511-3. PubMed ID: 17954160
    [Abstract] [Full Text] [Related]

  • 8. Impact of pretransplant MELD score on posttransplant outcome in orthotopic liver transplantation for patients with acute-on-chronic hepatitis B liver failure.
    Wang ZX, Yan LN, Wang WT, Xu MQ, Yang JY.
    Transplant Proc; 2007 Jun 15; 39(5):1501-4. PubMed ID: 17580172
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J, Rimola A, Laguno M, de Lazzari E, Rascón J, Agüero F, Blanco JL, Moitinho E, Moreno A, Miró JM, ESLD-HIV Working Group Investigators.
    Liver Transpl; 2009 Sep 15; 15(9):1133-41. PubMed ID: 19718643
    [Abstract] [Full Text] [Related]

  • 13. Prognostic impact of model for end-stage liver disease score in patients undergoing liver transplantation with suboptimal livers.
    Vitale A, D'Amico F, Brolese A, Zanus G, Boccagni P, Neri D, Gringeri E, Valmasoni M, Ciarleglio FA, Carraro A, Pauletto A, Bonsignore P, Bassi D, Polacco M, D'Amico DF, Cillo U.
    Transplant Proc; 2007 Sep 15; 39(6):1907-9. PubMed ID: 17692650
    [Abstract] [Full Text] [Related]

  • 14. Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system?
    Cuomo O, Perrella A, Arenga G.
    Transplant Proc; 2008 Sep 15; 40(6):1906-9. PubMed ID: 18675085
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. MELD and prediction of post-liver transplantation survival.
    Habib S, Berk B, Chang CC, Demetris AJ, Fontes P, Dvorchik I, Eghtesad B, Marcos A, Shakil AO.
    Liver Transpl; 2006 Mar 15; 12(3):440-7. PubMed ID: 16498643
    [Abstract] [Full Text] [Related]

  • 17. True impact of the indication of cirrhosis and the MELD on the results of liver transplantation.
    Santoyo J, Suarez MA, Fernandez-Aguilar JL, Perez Daga JA, Sanchez-Perez B, Ramirez C, Aranda JM, Rodríguez-Canete A, Gonzalez-Sanchez A.
    Transplant Proc; 2006 Oct 15; 38(8):2462-4. PubMed ID: 17097967
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Extended donor criteria have no negative impact on early outcome after liver transplantation: a single-center multivariate analysis.
    Schemmer P, Nickkholgh A, Hinz U, Gerling T, Mehrabi A, Sauer P, Encke J, Friess H, Weitz J, Büchler MW, Schmidt J.
    Transplant Proc; 2007 Mar 15; 39(2):529-34. PubMed ID: 17362774
    [Abstract] [Full Text] [Related]

  • 20. Aetiology of cirrhosis of the liver has an impact on survival predicted by the Model of End-stage Liver Disease score.
    Angermayr B, Luca A, König F, Bertolini G, Ploner M, Gridelli B, Ulbrich G, Reiberger T, Bosch J, Peck-Radosavljevic M.
    Eur J Clin Invest; 2009 Jan 15; 39(1):65-71. PubMed ID: 19087131
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.